Skip to main content
. 2022 Jul 18;9:922347. doi: 10.3389/fmed.2022.922347

FIGURE 4.

FIGURE 4

Quality control of iPSC-derived CMs. (A) Immunostaining of sarcomeric alpha-actinin (SAA) demonstrated the high ratio of CMs. (B) Flow cytometry revealed 82.5% iPSC had been differentiated into CMs.